XML 16 R20.htm IDEA: XBRL DOCUMENT v3.20.1
Collaboration Agreements (Tables)
3 Months Ended
Apr. 03, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Collaborative Revenues Under Collaboration Agreement
Revenues under the collaboration agreement with Takeda were as follows (in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
License revenues
$

 
$
9,056

Collaboration services revenues
1,069

 
2,437

Total
$
1,069

 
$
11,493


Revenues under the collaboration agreement with Ipsen were as follows (in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
License revenues
$
17,949

 
$
13,963

Collaboration services revenues
11,087

 
7,905

Total
$
29,036

 
$
21,868


License revenues under the collaboration agreement with Genentech were as follows (in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
Profits on U.S. commercialization
$
1,407

 
$
1,055

Royalty revenues on ex-U.S. sales
$
1,309

 
$
1,490